[Product Guide] Monoclonal Antibodies_Biosynth Carbosynth - 코아사이언스

Monoclonal Antibodies

 

Introduction 

Monoclonal antibodies (mAbs) typically bind to a single antigenic epitope (monovalent affinity). They can be produced using hybridomas or through recombinant production techniques. Biosynth Carbosynth offer a range of monoclonal antibodies for research against targets involved in cancer, multiple sclerosis, and other diseases. 

 

Cat.#	Cas No	Product	Description
BA165581	216503-57-0	Alemtuzumab	Monoclonal antibody against CD52; treatment for multiple sclerosis; anti-cancer
BA165582	1245916-14-6	Alirocumab - solution - 75 mg/ml	Monoclonal antibody to PCSK9 ; inhibitor of proprotein convertase PCSK9
BA165584	1380723-44-3	Atezolizumab	Monoclonal antibody against PDL-1; anti-cancer agent
BB164045	2088770-90-3	Brentuximab	Antibody-drug conjugate targeting CD30; antineoplastic
BD164046	1363687-32-4	Dinutuximab	Anti-GD2 monoclonal antibody
BD165585	615258-40-7	Denosumab	Monoclonal antibody against RANKL; anti-resorptive agent for osteoperosis treatment
BD165586	945721-28-8	Daratumumab - 20mg/ml in water	Monoclonal antibody against CD38; treatment for multiple myeloma
BE165588	219685-50-4	Eculizumab	Monoclonal antibody against complement protein C5
BE165589	1256937-27-5	Evolocumab - solution - 5 mg/ml	Inhibts PCSK9; hypercholesterolemia therapy
BI164048	477202-00-9	Ipilimumab	Monoclonal antibody against CTLA-4
BM165590	339186-68-4	Matuzumab - 10mg/ml	Intereferes with EGFR homodimerisation; cancer therapy
BM168494	196078-29-2	Mepolizumab	Monoclonal antibody for treatment of eosinophilic asthma
BN164047	946414-94-4	Nivolumab - >10mg/ml	Monoclonal antibody against PD-1 checkpoint protein
BN165591	780758-10-3	Nimotuzumab	Intereferes with EGFR ligand binding; cancer therapy
BO164044	679818-59-8	Ofatumumab	Monoclonal antibody against CD20
BO165592	949142-50-1	Obinutuzumab - Buffer solution	Activates B-cell apoptosis; treatment of B-cell malignancies
BP164049	1374853-91-4	Pembrolizumab - in storage buffer	Monoclonal antibody against PDL1; cancer immunotherapy
BP165593	380610-27-5	Pertuzumab	Blocks HER-2 heterodimerization; breast cancer therapy
BR167936	174722-31-7	Rituximab - 10mg/ml solution	Chimeric monoclonal antibody against CD20 Therapeutic monoclonal antibody in multiple sclerosis
FR138503	174722-31-7	Rituximab - 20mg/ml solution	Chimeric monoclonal antibody against CD20 Therapeutic monoclonal antibody in multiple sclerosis
BR171775	347396-82-1	Ranibizumab - 10mM histidine- histidine HCl buffer	Monoclonal antibody against VEGF-A
FR139132	347396-82-1	Ranibizumab - 25mg/ml solution in PBS	Monoclonal antibody against VEGF-A
BS165594	875356-43-7	Secukinumab	Inactivates IL-17A; psoriasis therapy
BU165596	815610-63-0	Ustekinumab	Inhibits pro-inflammatory cytokines IL-12 and IL-23; psoriasis therapy
BV165597	943609-66-3	Vedolizumab	Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapy
FC64978	205923-56-4	Cetuximab - Buffer solution	Monoclonal antibody against EGFR; treatment for colorectal cancer
FB168813	1407495-02-6	Bococizumab	Monoclonal antibody against PCSK9
BT165595	375823-41-9	Tocilizumab - 20mg/ml in PBS	Interleukin-6 competitor blocks IL-6 receptor; immunosuppressive agent.
FR159043	947687-13-0	Ramucirumab	Monoclonal antibody to VEGFR-2
FO139134	242138-07-4	Omalizumab - buffer solution	Monoclonal antibody against immunoglobulin E (IgE)
FP139135	188039-54-5	Palivizumab	Monoclonal antibody against the F protein of RSV
FP30153	339177-26-3	Panitumumab - buffer solution	Monoclonal antibody against EGFR
FI139130	170277-31-3	Infliximab	Chimeric monoclonal antibody against TNFα
FI139131	331731-18-1	Adalimumab	Monoclonal antibody against TNFα; therapy for rheumatoid arthritis
FT65040	180288-69-1	Trastuzumab - 20mg/ml in PBS	Monoclonal antibody against HER2 for breast cancer treatment
FN139133	189261-10-7	Natalizumab	Monoclonal antibody against α4-integrin
FB76708	216974-75-3	Bevacizumab - 25mg/ml solution in PBS	Monoclonal antibody against VEGF
BC176794	914613-48-2	Canakinumab	Monoclonal antibody against human interleukin-1β
FC181537	2415933-42-3	Casirivimab	Monoclonal antibody against spike protein RBD of SARSCoV-2
FI181538	2415933-40-1	Imdevimab	Monoclonal antibody against spike protein RBD of SARSCoV-2
DHC93560	1428935-60-7	Durvalumab	Monoclonal antibody against PD-L1
BA165583	1537032-82-8	Avelumab - in PBS buffer	Monoclonal antibody against PDL-1; targeted immunotherapy for cancer

 

* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.

 

코아사이언스 coresciences​ Biosynth Carbosynth limited UK Korea 한국 대리점 distributor